The generalized anxiety spectrum: prevalence, onset, course and outcome

  • Jules Angst
  • Alex Gamma
  • David S. Baldwin
  • Vladeta Ajdacic-Gross
  • Wulf Rössler



Generalized anxiety disorder (GAD) is generally considered to be a chronic condition, waxing and waning in severity; however prospective investigation of the course of GAD in community samples is lacking. This study seeks to fill that gap, by identifying the whole spectrum of generalized anxiety syndromes, sub-typing them according to their duration and frequency of occurrence, and evaluating their long-term course and outcome in the community.


The prospective Zurich Study assessed psychiatric and somatic syndromes in a community sample of young adults (N = 591) (aged 20 years at first interview) by six interviews over a period of 20 years (1979–1999). GAD syndromes were defined by DSM-III symptom criteria without applying any exclusion criteria. A spectrum of generalized anxiety was defined by duration: 6 months (DSM-IV), 1 month (DSM-III), ≤2 weeks (with weekly occurrence over one year), and anxiety symptoms. From 1978 (screening) to 1999 the annual presence of symptoms and treatment was assessed. Persistence of anxiety was defined by the almost daily presence of symptoms over the previous 12 months.


The annual incidence of DSM-III GAD increased considerably between the ages of 20 and 40. The average age of onset of symptoms was 15.6 years; in 75% of cases it occurred before the age of 20. 75 of 105 DSM-III GAD cases had at least one follow-up. At their individual last follow-up, 12 of those 75 subjects (16%) were re-diagnosed as having GAD, 22 (29%) manifested subthreshold syndromes or anxiety symptoms, while 39 cases, the majority, (52%) were symptom-free; 5 of the 12 re-diagnosed GAD cases were persistent (corresponding to 7% of all 75 initial GAD cases). In their twenties they were treated at some time in 6% of all years, but in their thirties this figure rose to 12%. At their individual last follow-up 26% of 6-month GAD subjects and 22% of 1-month GAD subjects were still being treated. Treated vs. non-treated subjects did not differ in terms of gender but did differ in severity, persistence and in comorbidity with bipolar-II disorder, social phobia, obsessive-compulsive syndromes and substance-use disorders.


Results are based on a relatively small sample and cannot be generalized to adults aged over 40 years.


The course of DSM-III-defined GAD may not be chronic, as previously suggested, but mainly recurrent with intervening symptom-free periods of recovery in about half of cases. Over a period of 20 years there was more improvement than progression within the anxiety spectrum.


generalized anxiety disorder incidence onset course outcome anxiety spectrum 


  1. 1.
    American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders: DSM-IV-TR. American Psychiatric Association, WashingtonGoogle Scholar
  2. 2.
    Anderson DJ, Noyes R, Crowe RR (1984) A comparison of panic disorder and generalized anxiety disorder. Am J Psychiatry 141:572–576PubMedGoogle Scholar
  3. 3.
    Angst J, Dobler-Mikola A, Binder J (1984) The Zurich Study—a prospective epidemiological study of depressive, neurotic and psychosomatic syndromes. I. Problem, methodology. Eur Arch Psychiatr Neurol Sci 234:13–20CrossRefGoogle Scholar
  4. 4.
    Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rössler W (2003) Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Affect Disord 73:133–146PubMedCrossRefGoogle Scholar
  5. 5.
    Angst J, Gamma A, Bienvenu OJ, Eaton WW, Ajdacic V, Eich D, Rössler W (2006) Varying temporal criteria for generalized anxiety disorder: prevalence and clinical charactersitics in a young age cohort. Psychol Med 36:1283–1292PubMedCrossRefGoogle Scholar
  6. 6.
    Angst J, Gamma A, Neuenschwander M, Ajdacic-Gross V, Eich D, Rössler W, Merikangas KR (2005) Prevalence of mental disorders in the Zurich cohort study: a 20 year prospective study. Epidemiol Psichiatr Soc 14:68–76PubMedGoogle Scholar
  7. 7.
    Angst J, Merikangas KR (1997) The depressive spectrum: diagnostic classification and course. J Affect Disord 45:31–40PubMedCrossRefGoogle Scholar
  8. 8.
    Angst J, Wicki W (1992) The Zurich study: XIII. Recurrent brief anxiety. Eur Arch Psychiatry Clin Neurosci 241:296–300PubMedCrossRefGoogle Scholar
  9. 9.
    Ballenger JC, Davidson JRT, Lecrubier Y, Nutt DJ, Borkovec TD, Rickels K, Stein DJ, Wittchen HU (2001) Consensus statement on generalized anxiety disorder from the international consensus group on depression and anxiety. J Clin Psychiatry 62:53–58PubMedGoogle Scholar
  10. 10.
    Barlow DH, Blanchard EB, Vermilyea JA, Vermilyea BB, Dinardo PA (1986) Generalized anxiety disorder: description and reconceptualization. Am J Psychiatry 143:40–44PubMedGoogle Scholar
  11. 11.
    Bienvenu OJ, Nestadt G, Eaton WW (1998) Characterizing generalized anxiety: temporal and symptomatic thresholds. J Nerv Ment Dis 186:51–56PubMedCrossRefGoogle Scholar
  12. 12.
    Blazer DG, Hughes D, George LK, Swartz M, Boyer R (1991) Generalized anxiety disorder. In: Robins LN, Regier DA (eds) Psychiatric disorders in America: the epidemiologic catchment area study. The Free Press, New York, pp 180–203Google Scholar
  13. 13.
    Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, Shea MT, Keller MB (2005) Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 162:1179–1187PubMedCrossRefGoogle Scholar
  14. 14.
    Carter RM, Wittchen HU, Pfister H, Kessler RC (2001) One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depress Anxiety 13:78–88PubMedCrossRefGoogle Scholar
  15. 15.
    Cayedo N, Griez EJL (2001) Generalised anxiety disorder. In: Griez EJL, Faravelli C, Nutt D, Zohar J (eds) Anxiety disorders. An introduction to clinical management and research. Wiley, Chichester, pp 187–204Google Scholar
  16. 16.
    Derogatis LR (1977) SCL-90. Administration, scoring and procedures manual-I for the R (revised) version and other instruments of the psychopathology rating scale series. Johns Hopkins University School of Medicine, ChicagoGoogle Scholar
  17. 17.
    Dunn G, Pickles A, Tansella M, Vazquez-Barquero J-L (1999) Two-phase epidemiological surveys in psychiatry. Br J Psychiatry 174:95–100PubMedCrossRefGoogle Scholar
  18. 18.
    Eich D, Ajdacic-Gross V, Condrau M, Huber H, Gamma A, Angst J, Rössler W (2003) The Zurich study: participation patterns and symptom checklist 90-R scores in six interviews, 1979–99. Acta Psychiatr Scand 108:S11–S14CrossRefGoogle Scholar
  19. 19.
    Judd LL, Kessler RC, Paulus MP, Zeller PV, Wittchen H-U, Kunovac JL (1998) Comorbidity as a fundamental feature of generalized anxiety disorders: results from the national comorbidity study (NCS). Acta Psychiatr Scand 98:6–11CrossRefGoogle Scholar
  20. 20.
    Kessler RC (2000) The epidemiology of pure and comorbid generalized anxiety disorder: a review and evaluation of recent research. Acta Psychiatr Scand 102:7–13CrossRefGoogle Scholar
  21. 21.
    Kessler RC, Brandenburg N, Lane M, Roy-Byrne P, Stang PD, Stein DJ, Wittchen HU (2005) Rethinking the duration requirement for generalized anxiety disorder: evidence from the national comorbidity survey replication. Psychol Med 35:1073–1082PubMedCrossRefGoogle Scholar
  22. 22.
    Kessler RC, Wittchen HU (2002) Patterns and correlates of generalized anxiety disorder in community samples. J Clin Psychiatry 63:4–10PubMedGoogle Scholar
  23. 23.
    Lester H, Gask L (2006) Delivering medical care for patients with serious mental illness or promoting a collaborative model of recovery? Br J Psychiatry 188:401–402PubMedCrossRefGoogle Scholar
  24. 24.
    Rickels K, Rynn MA (2001) What is generalized anxiety disorder? J Clin Psychiatry 62:4–12PubMedGoogle Scholar
  25. 25.
    Rubio G, López-Ibor JJ (2007) Generalized anxiety disorder: a 40-year follow-up study. Acta Psychiatr Scand 115:372–379PubMedCrossRefGoogle Scholar
  26. 26.
    Stein DJ (2001) Comorbidity in generalized anxiety disorder: impact and implications. J Clin Psychiatry 62:29–34PubMedGoogle Scholar
  27. 27.
    Wittchen HU (2002) Generalized anxiety disorder: prevalence, burden, and cost to society. Depress Anxiety 16:162–171PubMedCrossRefGoogle Scholar
  28. 28.
    Wittchen HU, Hoyer J (2001) Generalized anxiety disorder: nature and course. J Clin Psychiatry 62:15–19PubMedGoogle Scholar
  29. 29.
    Wittchen HU, Zhao S, Kessler RC, Eaton WW (1994) DSM-III-R generalized anxiety disorder in the national comorbidity survey. Arch Gen Psychiatry 51:355–364PubMedGoogle Scholar
  30. 30.
    Woodman CL, Noyes R, Black DW, Schlosser S, Yagla S (1999) A 5-year follow-up study of generalized anxiety disorder and panic disorder. J Nerv Ment Dis 187:3–9PubMedCrossRefGoogle Scholar
  31. 31.
    Yonkers KA, Bruce SE, Dyck IR, Keller MB (2003) Chronicity, relapse, and illness—course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up. Depress Anxiety 17:173–179PubMedCrossRefGoogle Scholar

Copyright information

© Steinkopff Verlag Darmstadt 2008

Authors and Affiliations

  • Jules Angst
    • 1
  • Alex Gamma
    • 1
  • David S. Baldwin
    • 2
  • Vladeta Ajdacic-Gross
    • 1
  • Wulf Rössler
    • 1
  1. 1.Zurich University Psychiatric HospitalZurichSwitzerland
  2. 2.Clinical Neuroscience Division, School of MedicineUniversity of SouthamptonSouthamptonUK

Personalised recommendations